I propose three groundbreaking CRISPR-based therapeutic strategies for Huntington's disease (HD) that go beyond simple huntingtin (HTT) gene knockdown. First, **selective allele-specific silencing using prime editing** to target only the expanded CAG repeat allele while preserving wild-type HTT function. Second, **CRISPR-mediated enhancement of proteostasis networks** by simultaneously upregulating multiple chaperone systems (HSP70, HSP40, and autophagy pathways) in striatal neurons. Third, **ep
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.60
Evidence
0.55
Novelty
0.60
Feasibility
0.00
Impact
0.00
Druggability
0.00
Safety
0.00
Competition
0.00
Data
0.00
Reproducible
0.00
KG Connect
0.50
Score Breakdown
Dimension
Novel CRISPR-based Therapies f
Mechanistic
0.600
Evidence
0.550
Novelty
0.600
Feasibility
0.000
Impact
0.000
Druggability
0.000
Safety
0.000
Competition
0.000
Data
0.000
Reproducible
0.000
KG Connect
0.500
Evidence
Novel CRISPR-based Therapies for Huntington's Disease: A Mul